ES471269A1 - Procedimiento para preparar derivados alfa-acetilenicos de aminas - Google Patents

Procedimiento para preparar derivados alfa-acetilenicos de aminas

Info

Publication number
ES471269A1
ES471269A1 ES471269A ES471269A ES471269A1 ES 471269 A1 ES471269 A1 ES 471269A1 ES 471269 A ES471269 A ES 471269A ES 471269 A ES471269 A ES 471269A ES 471269 A1 ES471269 A1 ES 471269A1
Authority
ES
Spain
Prior art keywords
hydrogen
image
carbon atoms
methylthioethyl
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES471269A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merrell Toraude et Cie
Original Assignee
Merrell Toraude et Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Toraude et Cie filed Critical Merrell Toraude et Cie
Publication of ES471269A1 publication Critical patent/ES471269A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Sales farmaeúticamente aceptables de los compuestos que incluyen sales de adición de ácido no tóxicas, formadas con ácido inorgánicos, tales como ácido clorhídrico, bromhidrico, sulfúrico y fosfórico y ácidos orgánicos, tales como ácido metano-sulfónico, salicilico, maleico, malónico, tartárico, cítrico, ciclámico y arcórbico. Son compuestos preferidos de este invento aquellos de la fórmula general I, en que Z es beta-metiltioetilo, S-(5''-desoxiadenosin-5''-il)-S-metiltioetilo, gamma-guanidinopropilo.
ES471269A 1977-07-01 1978-06-29 Procedimiento para preparar derivados alfa-acetilenicos de aminas Expired ES471269A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/812,265 US4139563A (en) 1977-07-01 1977-07-01 α-ACETYLENIC DERIVATIVES OF AMINES

Publications (1)

Publication Number Publication Date
ES471269A1 true ES471269A1 (es) 1979-10-01

Family

ID=25209053

Family Applications (1)

Application Number Title Priority Date Filing Date
ES471269A Expired ES471269A1 (es) 1977-07-01 1978-06-29 Procedimiento para preparar derivados alfa-acetilenicos de aminas

Country Status (14)

Country Link
US (1) US4139563A (es)
JP (1) JPS5481206A (es)
AU (1) AU517458B2 (es)
BE (1) BE868594A (es)
CA (1) CA1090790A (es)
CH (1) CH640820A5 (es)
DE (1) DE2827907A1 (es)
ES (1) ES471269A1 (es)
FR (1) FR2395990A1 (es)
GB (1) GB2001058B (es)
IT (1) IT1105054B (es)
NL (1) NL190115C (es)
NZ (1) NZ187543A (es)
ZA (1) ZA783355B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182891A (en) * 1977-07-01 1980-01-08 Merrell Toraude Et Compagnie α-Acetylenic derivatives of α-amino acids
US4456619A (en) * 1978-09-18 1984-06-26 Sandoz, Inc. Amides of 2-alkynoic acids and use for inhibiting accumulation of cholesterol ester in arterial walls
US4414395A (en) * 1980-03-13 1983-11-08 Ciba-Geigy Corporation Process for the manufacture of hydrazono-isoindolines
ZA811555B (en) * 1980-03-25 1982-03-31 Merrell Toraude & Co Substituted deoxyadenosine derivatives
PH16634A (en) * 1980-06-16 1983-12-05 Merrell Dow Pharma Method of inhibiting the growth of protozoa
US4437873A (en) 1981-03-23 1984-03-20 Merrell Dow Pharmaceuticals Inc. Method of inhibiting algae
IE54304B1 (en) * 1981-08-19 1989-08-16 Merrell Dow France Fluorinated diamino-heptene and -heptyne derivatives
US4376116A (en) * 1981-09-01 1983-03-08 Research Corporation Polyamine biosynthesis inhibitors
US4421768A (en) 1982-08-11 1983-12-20 Merrell Toraude Et Compagnie Fluorinated diamino-heptene and-heptyne derivatives
US4720489A (en) * 1984-10-15 1988-01-19 Douglas Shander Hair growth modification with ornithine decarboxylase inhibitors
JPS62148462A (ja) * 1985-12-19 1987-07-02 メレルダウフア−マス−テイカルズ　インコ−ポレ−テツド 原生動物の生長を抑制する新規な方法
US5196450A (en) * 1985-12-19 1993-03-23 Merrell Dow Pharmaceuticals Inc. Method of inhibiting protozoal growth
US4707498A (en) * 1986-01-14 1987-11-17 Merrell Dow Pharmaceuticals Inc. Fluorinated diaminoalkyne derivatives
US5366971A (en) * 1987-11-09 1994-11-22 Sandoz Ltd. Use of 11,28-dioxa-4-azatricyclo[22.3.1.04,9 ]octacos-18-ene derivatives and pharmaceutical compositions containing them
GB2212061B (en) * 1987-11-09 1991-08-28 Sandoz Ltd Topical compositions comprising 11,28-dioxa-4-azatricyclo [22.3.1.0(4,9)] octacos-18-ene derivatives
US5013719A (en) * 1988-05-13 1991-05-07 Merrell Dow Pharmaceuticals Inc. Method of effecting immunosuppression
AU2001268422A1 (en) 2000-06-15 2001-12-24 University Of Kentucky Research Foundation Agmatine and agmatine analogs in the treatment of epilepsy, seizure, and electroconvulsive disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2766285A (en) * 1952-10-20 1956-10-09 Lilly Co Eli Substituted aminopropynes and process for their preparation
US3024190A (en) * 1958-10-03 1962-03-06 Commercial Solvents Corp Process for the control of bacteria in a flooding process for the recovery of petroleum oil
US3160664A (en) * 1959-04-10 1964-12-08 Miles Lab Acetylenic omega-haloalkylamines
GB1041987A (en) * 1964-09-03 1966-09-07 Beecham Group Ltd Acetylenic compounds
US3291683A (en) * 1965-05-24 1966-12-13 American Cyanamid Co Controlling fungi and bacteria with alkoxy or alkylthio alkylamine ethers
FR1481067A (fr) * 1965-12-29 1967-05-19 Soc Ind Fab Antibiotiques Sifa Nouvelles nu-propynyl méthylamines et leurs sels et procédé de préparation
GB1161915A (en) * 1966-06-03 1969-08-20 Ciba Ltd Pharmaceutical Preparations comprising Sulphur-Containing Amino-Compounds for the Treatment of Depressive Conditions
US3960927A (en) * 1975-03-18 1976-06-01 Richardson-Merrell Inc. Olefinic derivatives of amino acids
FR2354100A2 (fr) * 1976-06-08 1978-01-06 Anvar Medicament a base de 5' thioethers de l'adenosine

Also Published As

Publication number Publication date
IT1105054B (it) 1985-10-28
US4139563A (en) 1979-02-13
BE868594A (fr) 1978-10-16
NZ187543A (en) 1982-03-30
NL190115B (nl) 1993-06-01
GB2001058B (en) 1982-02-03
DE2827907C2 (es) 1987-10-01
FR2395990A1 (fr) 1979-01-26
DE2827907A1 (de) 1979-01-11
AU517458B2 (en) 1981-07-30
AU3732078A (en) 1980-01-03
CA1090790A (en) 1980-12-02
JPS6216941B2 (es) 1987-04-15
FR2395990B1 (es) 1980-07-18
NL190115C (nl) 1993-11-01
CH640820A5 (de) 1984-01-31
GB2001058A (en) 1979-01-24
IT7850078A0 (it) 1978-06-28
JPS5481206A (en) 1979-06-28
ZA783355B (en) 1979-06-27
NL7807090A (nl) 1979-01-03

Similar Documents

Publication Publication Date Title
ES472738A1 (es) Procedimiento para la obtencion de alfa-halometil derivados de aminas
ES471269A1 (es) Procedimiento para preparar derivados alfa-acetilenicos de aminas
ES473074A1 (es) Un procedimiento para la preparacion de derivados de tieno- tiacina
ES455804A1 (es) Un procedimiento de preparacion de nuevos derivados del aci-do 3-quinolein- carboxilico.
ES422581A1 (es) Procedimiento de preparacion de derivados piridinicos.
IE790064L (en) Tetrahydropyridinylindoles
ES445660A1 (es) Procedimiento para preparar acidos w-acetileno-w-amino-alca-noicos y 2-alquenoicos.
ES471268A1 (es) Procedimiento para la preparacion de derivados alfa-acetile-nicos de alfa-amino acidos
ES8200108A1 (es) Un procedimiento para la preparacion de derivados de tioxan tina.
ES471863A1 (es) Procedimiento para preparar derivados indolicos
ES466143A1 (es) Un procedimiento de preparacion de nuevas imidazoquinoleinas
ES470271A1 (es) Procedimiento para la preparacion de nuevos derivados de 5, 11-dhidro-6h-pirido (2,3-b) (1,4) benzodiazepin-6-ona
IE45141L (en) Prostaglandin derivatives
IE44627L (en) m-TRIFLUOROMETHYLPHENYL-PIPERIDINES.
ES447646A1 (es) Procedimiento para la preparacion de nuevas tiazolinas.
ES8303316A1 (es) Un procedimiento para la fabricacion de un disulfuro intra ointermolecular
ES477481A1 (es) Procedimiento para preparar nuevos derivados de 3-feniltetrahidropiridina.
ES377892A1 (es) Procedimiento para la preparacion de 10-piperazino-10,11 - dihidrodibenzo (b, f) tiepinas sustituidas en posicion 8.
ES8200648A2 (es) Procedimiento de preparacion de compuestos opacificantes para radiografia y similares
ES8203917A1 (es) Un procedimiento para la preparacion de un derivado de nu- cleosido de adenina
JPS5344580A (en) 1,6-dihydropyridazine derivatives
ES451067A1 (es) Un procedimiento de preparacion de derivados de fenotiazina.
ES8301931A1 (es) Un procedimiento para la preparacion de nuevos imidazoles.
ES467791A1 (es) Procedimiento para la obtencion de nuevos derivados del 1- fenil-2-amino-1,3-propandiol-n-alcohilo.
ES474985A1 (es) Procedimiento para la preparacion de derivados de la isoqui-noleina